Question Title

* 1. Please enter your contact information:

Question Title

* 2. Which of the following statements is true?

Question Title

* 3. What reduction in stroke was observed in the COMPASS study for patients receiving the vascular dose of rivaroxaban?

Question Title

* 4. What dose of rivaroxaban produced the significant effects on MACE and mortality in COMPASS?

Question Title

* 5. What reduction in mortality was seen in patients receiving the vascular dose of rivaroxaban?

Question Title

* 6. Which patient group benefited the most from the vascular dose of rivaroxaban in the COMPASS trial?

Question Title

* 7. True or false, the vascular dose of rivaroxaban has both a European and US marketing authorisation?

0 of 7 answered
 

T